PMS2 and cancer: Similarly, the observed risk of dying from ovarian cancer in path_MSH6 or path_PMS2 carriers diagnosed before 50 years of age was 0%, and in these carriers, prophylactic oophorectomy before 50 years of age solely for cancer prevention reasons is considered unwarranted and unethical [41].